Last week, the American Society of Law, Medicine & Ethics held its annual Health Law Professors conference—and my own institution, Georgia State University College of Law, had the pleasure of hosting the conference.
Goodbye, Y’all! Thanks for a great @ASLMENews Health Law Prof Conf. See you next year in Cleveland, OH, @CaseWestern! #HLP17 pic.twitter.com/QByDWSE8p4
— GSU Health Law (@GSU_HealthLaw) June 10, 2017
Over two hundred law professors and attorneys gathered to discuss their work, and, as has been the case for at least the past several years that I have attended, there were many fantastic presentations relevant to those of us in the FDA world. Topics included, among others, the First Amendment, prescription drug advertising and promotion, drug pricing, human subjects protection, food policy and health behaviors, the opioid crisis, medical marijuana, genetic information and technologies, vaccines, antimicrobial resistance, innovation incentives for biomedical technologies, and regenerative medicine.
For those interested in getting a better sense of what was discussed, the conference agenda is here and the conference hashtag was #HLP17.